Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 57560
Gene Symbol: IFT80
IFT80
0.010 AlteredExpression disease BEFREE Collectively, the data from the present study demonstrated that the ATD2 gene was frequently amplified and protein expression levels were upregulated in OC. 31746426 2020
Entrez Id: 101927597
Gene Symbol: NCK1-DT
NCK1-DT
0.010 AlteredExpression disease BEFREE As for mechanistic investigation, starBase (http://starbase.sysu.edu.cn/) suggested that NCK1-AS1 expression in OC tissues was significantly positively correlated with its adjacent gene, NCK adaptor protein 1 (NCK1). 31761329 2020
Entrez Id: 23586
Gene Symbol: DDX58
DDX58
0.010 AlteredExpression disease BEFREE High RIG-I expression in ovarian cancer associates with an immune-escape signature and poor clinical outcome. 31800094 2020
Entrez Id: 29123
Gene Symbol: ANKRD11
ANKRD11
0.010 GeneticVariation disease BEFREE Two new putative OC risk genes were identified, namely, ANKRD11, a putative tumor suppressor, and POLE, an enzyme involved in DNA repair and replication. 31265121 2020
Entrez Id: 10321
Gene Symbol: CRISP3
CRISP3
0.010 Biomarker disease BEFREE Complete or near-complete pathologic response assessed in the omental specimens of advanced epithelial ovarian carcinoma patients after neoadjuvant chemotherapy (CRS3) is predictive of prolonged progression-free and overall survival. 31754067 2020
Entrez Id: 100302285
Gene Symbol: MIR1244-1
MIR1244-1
0.010 Biomarker disease BEFREE Our study shows that LINC00504 promotes OC cell progression and stimulates aerobic glycolysis by interacting with miR-1244, which indicates that LINC00504 might act as a promising therapeutic target for OC treatment. 31691157 2020
Entrez Id: 126014
Gene Symbol: OSCAR
OSCAR
0.010 Biomarker disease BEFREE The OSCAR (NCT01863693) study assessed the impact of front-line bevacizumab-containing therapy on safety and oncologic outcomes in patients with advanced ovarian cancer in the UK. 31780570 2020
Entrez Id: 55833
Gene Symbol: UBAP2
UBAP2
0.010 Biomarker disease BEFREE CircRNA UBAP2 promotes the progression of ovarian cancer by sponging microRNA-144. 31539115 2019
Entrez Id: 1874
Gene Symbol: E2F4
E2F4
0.010 Biomarker disease BEFREE From protein-protein interaction network (PPI) analysis, modules, microRNA-target gene regulatory network and TFs-target gene regulatory network for up- and down-regulated, and the top hub genes such as E2F4, SRPK2, A2M, CDH1, MAP1LC3A, UCHL1, HLA-C (major histocompatibility complex, class I, C) , VAT1, ECM1 and SNRPN (small nuclear ribonucleoprotein polypeptide N) were associated in pathogenesis of EOC. 30970615 2019
Entrez Id: 2317
Gene Symbol: FLNB
FLNB
0.010 Biomarker disease BEFREE Taken together, LncRNA-ROR promoted EMT by the miR-145/FLNB regulatory axis in ovarian cancer, providing a potential therapeutic target for ovarian cancer. 31829305 2019
Entrez Id: 1052
Gene Symbol: CEBPD
CEBPD
0.010 Biomarker disease BEFREE CEBPD andMID2 were associated with the worst overall survival rates in EOC. 30970615 2019
Entrez Id: 2274
Gene Symbol: FHL2
FHL2
0.010 Biomarker disease BEFREE Our findings indicate that the miR-340-FHL2 axis regulates Wnt/β-catenin signaling and is involved in tumorigenesis in OC. 31068580 2019
Entrez Id: 374654
Gene Symbol: KIF7
KIF7
0.010 Biomarker disease BEFREE In conclusion, KIF7 has a tumor suppressor role in epithelial ovarian cancer and is a useful independent prognostic predictor. 31658044 2019
Entrez Id: 3909
Gene Symbol: LAMA3
LAMA3
0.010 Biomarker disease BEFREE Correlation of laminin subunit α3 (<i>LAMA3</i>) gene with onset and prognosis of ovarian cancer was investigated. 31402958 2019
Entrez Id: 728113
Gene Symbol: ANXA8L1
ANXA8L1
0.010 Biomarker disease BEFREE Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins. 31474227 2019
Entrez Id: 9319
Gene Symbol: TRIP13
TRIP13
0.010 AlteredExpression disease BEFREE The results of RT-PCR also indicated that TRIP13 expression was markedly upregulated in EOC cell lines (SKOV-3, HEY and OVCAR-3) compared to normal ovarian cell lines. 30720159 2019
Entrez Id: 6990
Gene Symbol: DYNLT3
DYNLT3
0.010 Biomarker disease BEFREE DYNLT3 may be a potential prognostic predictor in ovarian cancer. 31308737 2019
Entrez Id: 9232
Gene Symbol: PTTG1
PTTG1
0.010 Biomarker disease BEFREE PTTG1: a Unique Regulator of Stem/Cancer Stem Cells in the Ovary and Ovarian Cancer. 31482269 2019
Entrez Id: 462
Gene Symbol: SERPINC1
SERPINC1
0.010 Biomarker disease BEFREE ApoE multiplexed with EpCAM, plg, serpinC1 and C1q provide optimal diagnostic information for EOC with AUC = 0.913 (95% confidence interval (CI) =0.848-0.957, p < 0.0001). 31718609 2019
Entrez Id: 8788
Gene Symbol: DLK1
DLK1
0.010 AlteredExpression disease BEFREE Tissue microarray (TMA) consisting of surgically resected samples from 221 patients with ovarian carcinoma was constructed for DLK1 expression. 30626939 2019
Entrez Id: 10365
Gene Symbol: KLF2
KLF2
0.010 Biomarker disease BEFREE The rescue experiments were conducted to elucidate the biological function of LINC00702/KLF2 axis in the progression of OC. 31389610 2019
Entrez Id: 2316
Gene Symbol: FLNA
FLNA
0.010 Biomarker disease BEFREE Asparagine Synthetase and Filamin A Have Different Roles in Ovarian Cancer. 31681605 2019
Entrez Id: 6441
Gene Symbol: SFTPD
SFTPD
0.010 AlteredExpression disease BEFREE SP-D mRNA was found to be expressed widely in different types of ovarian cancer irrespective of stage or grade. 31338320 2019
Entrez Id: 25945
Gene Symbol: NECTIN3
NECTIN3
0.010 Biomarker disease BEFREE Nectin-3 may be a new biomarker for OC diagnosis. 30469078 2019
Entrez Id: 692205
Gene Symbol: SNORD89
SNORD89
0.010 Biomarker disease BEFREE Consequently, SNORD89 can be a novel prognostic biomarker and therapeutic target for ovarian cancer. 31395064 2019